US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 0.538
  • +0.004+0.75%
Close Jan 3 16:00 ET
29.71MMarket Cap-0.22P/E (TTM)

Marinus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marinus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.476M--
--2024/Q4-- / 10.591M--
--2024/Q38.541M / 9.422M--
Aug 13, 20242024/Q28.056M / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.476M--
--2024/Q4-- / 10.591M--
--2024/Q38.541M / 9.422M--
Aug 13, 20242024/Q28.056M / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--

Unlock Free Earnings Estimates

Marinus Pharmaceuticals Earnings Reports

  • Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

    Nov 12, 2024 16:46 ET

  • Marinus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 16:16 ET

  • Marinus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13, 2024 08:02 ET

  • Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

    Aug 13, 2024 07:13 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 5, 2025

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data